Trial · NCT07428369
Registered outcomes74
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 74
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Occurrence of Treatment-Emergent Adverse Events (TEAEs) | Up to day 112 | Phase 2 |
| Primary | Severity of TEAEs | Up to day 112 | Phase 2 |
| Primary | Achievement of Complete Response or better (≥CR) per International Myeloma Working Group (IMWG) criteria | Up to day 112 | Phase 2 |
| Primary | Minimal Residual Disease (MRD) negative CR at 10^-5 per IMWG criteria | Up to 12 months | Phase 3 |
| Primary | Progression Free Survival (PFS) per IMWG | Up to 5 years | Phase 3 |
| Secondary | Occurrence of TEAEs | Up to 3.5 years | Phase 2 |
| Secondary | Severity of TEAEs | Up to 3.5 years | Phase 2 |
| Secondary | Occurrence of Serious Adverse Events (SAEs) | Up to 3.5 years | Phase 2 |
| Secondary | Severity of SAEs | Up to 3.5 years | Phase 2 |
| Secondary | Occurrence of Cytokine Release Syndrome (CRS) | Up to day 30 | Phase 2 |
| Secondary | Severity of CRS | Up to day 30 | Phase 2 |
| Secondary | Occurrence of Cell-Associated Neurotoxicity Syndrome (ICANS) | Up to day 30 | Phase 2 |
| Secondary | Severity of ICANS | Up to day 30 | Phase 2 |
| Secondary | Achievement of objective response [Partial Response or better (≥PR)] per IMWG criteria | Up to 5 years | |
| Secondary | Time to ≥PR per IMWG criteria | Up to 5 years | |
| Secondary | Time to Very Good Partial Response or better (≥VGPR) per IMWG criteria | Up to 5 years | |
| Secondary | Time to ≥CR per IMWG criteria | Up to 5 years | |
| Secondary | Achievement of MRD negative (at 10^-5 sensitivity) CR per IMWG criteria | Up to 5 years | |
| Secondary | Duration Of Response (DOR) of ≥PR per IMWG criteria | Up to 5 years | |
| Secondary | Duration of ≥VGPR per IMWG criteria | Up to 5 years |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07428369/registered